http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2025, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 15 May 2025 16:40:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Poseida+Therapeutics%2C++++++++++++++++++Filed+by%3A+NOMURA+HOLDINGS+INC/24809439.html si-local-file:///var/storage/secattach/20250515/24809439.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Poseida+Therapeutics%2C++++++++++++++++++Filed+by%3A+NOMURA+HOLDINGS+INC/24809439.html Thu, 15 May 2025 16:40:00 -0400 O.47988829 PSTX http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Poseida+Therapeutics%2C++++++++++++++++++Filed+by%3A+NOMURA+HOLDINGS+INC/24809439.html si-local-file:///var/storage/secattach/20250515/24809439.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Poseida+Therapeutics%2C++++++++++++++++++Filed+by%3A+NOMURA+HOLDINGS+INC/24809439.html Thu, 15 May 2025 16:40:00 -0400 O.47988829 PSTX http://www.streetinsider.com/Press+Releases/Bright+Peak+Therapeutics+Appoints+John+Schmid+to+its+Board+of+Directors/24650715.html <p align="left">SAN DIEGO and BASEL, Switzerland , April 17, 2025 (GLOBE NEWSWIRE) -- Bright Peak Therapeutics, a clinical-stage biotechnology company focused on discovering and developing multifunctional immunotherapies for cancer, today announced the appointment of John Schmid, a seasoned biotechnology executive, to its Board of Directors.</p> <p>“It is a pleasure to welcome John to our Board,” said Fredrik Wiklund, Chief Executive Officer of Bright Peak Therapeutics. “John brings decades of experience and an extensive track record of success in the biotech sector. His strategic insights and financial expertise will be instrumental as we advance our clinical http://www.streetinsider.com/Press+Releases/Bright+Peak+Therapeutics+Appoints+John+Schmid+to+its+Board+of+Directors/24650715.html Thu, 17 Apr 2025 07:00:00 -0400 ANAB DSGN HLXA PSTX XERS http://www.streetinsider.com/Press+Releases/Bright+Peak+Therapeutics+Appoints+John+Schmid+to+its+Board+of+Directors/24650715.html <p align="left">SAN DIEGO and BASEL, Switzerland , April 17, 2025 (GLOBE NEWSWIRE) -- Bright Peak Therapeutics, a clinical-stage biotechnology company focused on discovering and developing multifunctional immunotherapies for cancer, today announced the appointment of John Schmid, a seasoned biotechnology executive, to its Board of Directors.</p> <p>“It is a pleasure to welcome John to our Board,” said Fredrik Wiklund, Chief Executive Officer of Bright Peak Therapeutics. “John brings decades of experience and an extensive track record of success in the biotech sector. His strategic insights and financial expertise will be instrumental as we advance our clinical http://www.streetinsider.com/Press+Releases/Bright+Peak+Therapeutics+Appoints+John+Schmid+to+its+Board+of+Directors/24650715.html Thu, 17 Apr 2025 07:00:00 -0400 ANAB DSGN HLXA PSTX XERS http://www.streetinsider.com/Press+Releases/Bright+Peak+Therapeutics+Appoints+John+Schmid+to+its+Board+of+Directors/24650715.html <p align="left">SAN DIEGO and BASEL, Switzerland , April 17, 2025 (GLOBE NEWSWIRE) -- Bright Peak Therapeutics, a clinical-stage biotechnology company focused on discovering and developing multifunctional immunotherapies for cancer, today announced the appointment of John Schmid, a seasoned biotechnology executive, to its Board of Directors.</p> <p>“It is a pleasure to welcome John to our Board,” said Fredrik Wiklund, Chief Executive Officer of Bright Peak Therapeutics. “John brings decades of experience and an extensive track record of success in the biotech sector. His strategic insights and financial expertise will be instrumental as we advance our clinical http://www.streetinsider.com/Press+Releases/Bright+Peak+Therapeutics+Appoints+John+Schmid+to+its+Board+of+Directors/24650715.html Thu, 17 Apr 2025 07:00:00 -0400 ANAB DSGN HLXA PSTX XERS http://www.streetinsider.com/Press+Releases/Bright+Peak+Therapeutics+Appoints+John+Schmid+to+its+Board+of+Directors/24650715.html <p align="left">SAN DIEGO and BASEL, Switzerland , April 17, 2025 (GLOBE NEWSWIRE) -- Bright Peak Therapeutics, a clinical-stage biotechnology company focused on discovering and developing multifunctional immunotherapies for cancer, today announced the appointment of John Schmid, a seasoned biotechnology executive, to its Board of Directors.</p> <p>“It is a pleasure to welcome John to our Board,” said Fredrik Wiklund, Chief Executive Officer of Bright Peak Therapeutics. “John brings decades of experience and an extensive track record of success in the biotech sector. His strategic insights and financial expertise will be instrumental as we advance our clinical http://www.streetinsider.com/Press+Releases/Bright+Peak+Therapeutics+Appoints+John+Schmid+to+its+Board+of+Directors/24650715.html Thu, 17 Apr 2025 07:00:00 -0400 ANAB DSGN HLXA PSTX XERS http://www.streetinsider.com/Press+Releases/Bright+Peak+Therapeutics+Appoints+John+Schmid+to+its+Board+of+Directors/24650715.html <p align="left">SAN DIEGO and BASEL, Switzerland , April 17, 2025 (GLOBE NEWSWIRE) -- Bright Peak Therapeutics, a clinical-stage biotechnology company focused on discovering and developing multifunctional immunotherapies for cancer, today announced the appointment of John Schmid, a seasoned biotechnology executive, to its Board of Directors.</p> <p>“It is a pleasure to welcome John to our Board,” said Fredrik Wiklund, Chief Executive Officer of Bright Peak Therapeutics. “John brings decades of experience and an extensive track record of success in the biotech sector. His strategic insights and financial expertise will be instrumental as we advance our clinical http://www.streetinsider.com/Press+Releases/Bright+Peak+Therapeutics+Appoints+John+Schmid+to+its+Board+of+Directors/24650715.html Thu, 17 Apr 2025 07:00:00 -0400 ANAB DSGN HLXA PSTX XERS http://www.streetinsider.com/Globe+Newswire/Bright+Peak+Therapeutics+Appoints+John+Schmid+to+its+Board+of+Directors/24650715.html <p align="left">SAN DIEGO and BASEL, Switzerland , April 17, 2025 (GLOBE NEWSWIRE) -- Bright Peak Therapeutics, a clinical-stage biotechnology company focused on discovering and developing multifunctional immunotherapies for cancer, today announced the appointment of John Schmid, a seasoned biotechnology executive, to its Board of Directors.</p> <p>“It is a pleasure to welcome John to our Board,” said Fredrik Wiklund, Chief Executive Officer of Bright Peak Therapeutics. “John brings decades of experience and an extensive track record of success in the biotech sector. His strategic insights and financial expertise will be instrumental as we advance our clinical http://www.streetinsider.com/Globe+Newswire/Bright+Peak+Therapeutics+Appoints+John+Schmid+to+its+Board+of+Directors/24650715.html Thu, 17 Apr 2025 07:00:00 -0400 ANAB DSGN HLXA PSTX XERS http://www.streetinsider.com/Globe+Newswire/Bright+Peak+Therapeutics+Appoints+John+Schmid+to+its+Board+of+Directors/24650715.html <p align="left">SAN DIEGO and BASEL, Switzerland , April 17, 2025 (GLOBE NEWSWIRE) -- Bright Peak Therapeutics, a clinical-stage biotechnology company focused on discovering and developing multifunctional immunotherapies for cancer, today announced the appointment of John Schmid, a seasoned biotechnology executive, to its Board of Directors.</p> <p>“It is a pleasure to welcome John to our Board,” said Fredrik Wiklund, Chief Executive Officer of Bright Peak Therapeutics. “John brings decades of experience and an extensive track record of success in the biotech sector. His strategic insights and financial expertise will be instrumental as we advance our clinical http://www.streetinsider.com/Globe+Newswire/Bright+Peak+Therapeutics+Appoints+John+Schmid+to+its+Board+of+Directors/24650715.html Thu, 17 Apr 2025 07:00:00 -0400 ANAB DSGN HLXA PSTX XERS http://www.streetinsider.com/Globe+Newswire/Bright+Peak+Therapeutics+Appoints+John+Schmid+to+its+Board+of+Directors/24650715.html <p align="left">SAN DIEGO and BASEL, Switzerland , April 17, 2025 (GLOBE NEWSWIRE) -- Bright Peak Therapeutics, a clinical-stage biotechnology company focused on discovering and developing multifunctional immunotherapies for cancer, today announced the appointment of John Schmid, a seasoned biotechnology executive, to its Board of Directors.</p> <p>“It is a pleasure to welcome John to our Board,” said Fredrik Wiklund, Chief Executive Officer of Bright Peak Therapeutics. “John brings decades of experience and an extensive track record of success in the biotech sector. His strategic insights and financial expertise will be instrumental as we advance our clinical http://www.streetinsider.com/Globe+Newswire/Bright+Peak+Therapeutics+Appoints+John+Schmid+to+its+Board+of+Directors/24650715.html Thu, 17 Apr 2025 07:00:00 -0400 ANAB DSGN HLXA PSTX XERS http://www.streetinsider.com/Globe+Newswire/Bright+Peak+Therapeutics+Appoints+John+Schmid+to+its+Board+of+Directors/24650715.html <p align="left">SAN DIEGO and BASEL, Switzerland , April 17, 2025 (GLOBE NEWSWIRE) -- Bright Peak Therapeutics, a clinical-stage biotechnology company focused on discovering and developing multifunctional immunotherapies for cancer, today announced the appointment of John Schmid, a seasoned biotechnology executive, to its Board of Directors.</p> <p>“It is a pleasure to welcome John to our Board,” said Fredrik Wiklund, Chief Executive Officer of Bright Peak Therapeutics. “John brings decades of experience and an extensive track record of success in the biotech sector. His strategic insights and financial expertise will be instrumental as we advance our clinical http://www.streetinsider.com/Globe+Newswire/Bright+Peak+Therapeutics+Appoints+John+Schmid+to+its+Board+of+Directors/24650715.html Thu, 17 Apr 2025 07:00:00 -0400 ANAB DSGN HLXA PSTX XERS http://www.streetinsider.com/Globe+Newswire/Bright+Peak+Therapeutics+Appoints+John+Schmid+to+its+Board+of+Directors/24650715.html <p align="left">SAN DIEGO and BASEL, Switzerland , April 17, 2025 (GLOBE NEWSWIRE) -- Bright Peak Therapeutics, a clinical-stage biotechnology company focused on discovering and developing multifunctional immunotherapies for cancer, today announced the appointment of John Schmid, a seasoned biotechnology executive, to its Board of Directors.</p> <p>“It is a pleasure to welcome John to our Board,” said Fredrik Wiklund, Chief Executive Officer of Bright Peak Therapeutics. “John brings decades of experience and an extensive track record of success in the biotech sector. His strategic insights and financial expertise will be instrumental as we advance our clinical http://www.streetinsider.com/Globe+Newswire/Bright+Peak+Therapeutics+Appoints+John+Schmid+to+its+Board+of+Directors/24650715.html Thu, 17 Apr 2025 07:00:00 -0400 ANAB DSGN HLXA PSTX XERS http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Poseida+Therapeutics%2C++++++++++++++++++Filed+by%3A+NOMURA+HOLDINGS+INC/24356154.html si-local-file:///var/storage/secattach/20250214/24356154.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Poseida+Therapeutics%2C++++++++++++++++++Filed+by%3A+NOMURA+HOLDINGS+INC/24356154.html Fri, 14 Feb 2025 16:55:00 -0400 O.47988829 PSTX http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Poseida+Therapeutics%2C++++++++++++++++++Filed+by%3A+NOMURA+HOLDINGS+INC/24356154.html si-local-file:///var/storage/secattach/20250214/24356154.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Poseida+Therapeutics%2C++++++++++++++++++Filed+by%3A+NOMURA+HOLDINGS+INC/24356154.html Fri, 14 Feb 2025 16:55:00 -0400 O.47988829 PSTX http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Poseida+Therapeutics%2C++++++++++++++++++Filed+by%3A+FMR+LLC/24313725.html si-local-file:///var/storage/secattach/20250207/24313725.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Poseida+Therapeutics%2C++++++++++++++++++Filed+by%3A+FMR+LLC/24313725.html Fri, 07 Feb 2025 10:24:00 -0400 O.47988829 PSTX http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Poseida+Therapeutics%2C++++++++++++++++++Filed+by%3A+FMR+LLC/24313725.html si-local-file:///var/storage/secattach/20250207/24313725.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Poseida+Therapeutics%2C++++++++++++++++++Filed+by%3A+FMR+LLC/24313725.html Fri, 07 Feb 2025 10:24:00 -0400 O.47988829 PSTX http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Poseida+Therapeutics%2C++++++++++++++++++Filed+by%3A+FMR+LLC/24313609.html si-local-file:///var/storage/secattach/20250207/24313609.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Poseida+Therapeutics%2C++++++++++++++++++Filed+by%3A+FMR+LLC/24313609.html Fri, 07 Feb 2025 10:06:00 -0400 O.47988829 PSTX http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Poseida+Therapeutics%2C++++++++++++++++++Filed+by%3A+FMR+LLC/24313609.html si-local-file:///var/storage/secattach/20250207/24313609.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Poseida+Therapeutics%2C++++++++++++++++++Filed+by%3A+FMR+LLC/24313609.html Fri, 07 Feb 2025 10:06:00 -0400 O.47988829 PSTX http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++Poseida+Therapeutics%2C++++++++++++++++/24225612.html si-local-file:///var/storage/secattach/20250121/24225612.html http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++Poseida+Therapeutics%2C++++++++++++++++/24225612.html Tue, 21 Jan 2025 06:05:00 -0400 O.47988829 PSTX http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++Poseida+Therapeutics%2C++++++++++++++++/24225612.html si-local-file:///var/storage/secattach/20250121/24225612.html http://www.streetinsider.com/SEC+Filings/Form++15-12G+++++Poseida+Therapeutics%2C++++++++++++++++/24225612.html Tue, 21 Jan 2025 06:05:00 -0400 O.47988829 PSTX http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Poseida+Therapeutics%2C++++++++++++++++++Filed+by%3A+Malin+Life+Sciences+Holdings+Ltd/24212500.html si-local-file:///var/storage/secattach/20250115/24212500.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Poseida+Therapeutics%2C++++++++++++++++++Filed+by%3A+Malin+Life+Sciences+Holdings+Ltd/24212500.html Wed, 15 Jan 2025 16:27:00 -0400 O.47988829 PSTX http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Poseida+Therapeutics%2C++++++++++++++++++Filed+by%3A+Malin+Life+Sciences+Holdings+Ltd/24212500.html si-local-file:///var/storage/secattach/20250115/24212500.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Poseida+Therapeutics%2C++++++++++++++++++Filed+by%3A+Malin+Life+Sciences+Holdings+Ltd/24212500.html Wed, 15 Jan 2025 16:27:00 -0400 O.47988829 PSTX http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Poseida+Therapeutics%2C++++++++++++++++++Filed+by%3A+Pentwater+Capital+Management+LP/24200779.html si-local-file:///var/storage/secattach/20250113/24200779.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Poseida+Therapeutics%2C++++++++++++++++++Filed+by%3A+Pentwater+Capital+Management+LP/24200779.html Mon, 13 Jan 2025 16:05:00 -0400 O.47988829 PSTX http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Poseida+Therapeutics%2C++++++++++++++++++Filed+by%3A+Pentwater+Capital+Management+LP/24200779.html si-local-file:///var/storage/secattach/20250113/24200779.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Poseida+Therapeutics%2C++++++++++++++++++Filed+by%3A+Pentwater+Capital+Management+LP/24200779.html Mon, 13 Jan 2025 16:05:00 -0400 O.47988829 PSTX http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Poseida+Therapeutics%2C++++++++++++++++/24197720.html si-local-file:///var/storage/secattach/20250113/24197720.html http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Poseida+Therapeutics%2C++++++++++++++++/24197720.html Mon, 13 Jan 2025 07:25:00 -0400 O.47988829 PSTX